Home

USER GUIDE

image

Contents

1. Drug Shortage list You can use the Formulary Search tool to find more information on how a drug is covered e g the maximum price that PharmaCare covers and whether the drug requires prior Special Authority 3 If PharmaCare cannot find a commercially manufactured alternate drug it may decide to cover a compounded made to order drug on a last resort basis during the shortage or it may advise patients and prescribers to consider alternate treatment plans PharmaCare s decision is detailed in the Alternate Drug section of the Current Drug Shortage list During a shortage PharmaCare regularly checks on the status of the shorted drug and updates the Current Drug Shortages List as required PharmaCare Drug Shortages Lists User Guide When a manufacturer confirms that a drug is available again to wholesalers and pharmacies PharmaCare updates the Current Drug Shortage with this information and with the day on which temporary coverage of the replacement drug will end On the day coverage of a replacement drug ends information on the drug shortage is removed from the Current Drug Shortages List and moved to the Resolved Drug Shortages List HOW THE INFORMATION IS PRESENTED Details about current shortages and resolved shortages are provided in separate Excel spreadsheets Both spreadsheets contain the same information organized the same way Information for each drug is organized into three sections 1 Shorted drug provid
2. Column name A Date reported yyyy mm dd Chemical name Strength Dosage form Brand name DIN PIN NPN G Manufacturer H 3 Availability Status Description Date on which HIBC first confirms the shortage The scientific name for the active chemical ingredient s of the shorted drug The per unit strength of the shorted drug e g 100 mg 100 mg in each tablet The dosage form of the shorted drug e g tablet capsule liquid Name the product is sold under also known as the Trade name Unique identification number for the shorted drug Company that sells the drug Current availability of shorted drug Date is in yyyy mm dd format to allow for sorting by date mg milligram mcg microgram ml millilitre mg ml milligram per millilitre of liquid Note this list is not complete DIN Drug Identification Number for prescription drugs PIN Product Identification Number assigned by PharmaCare PINs are used for products such as blood glucose test strips or compounded drugs NPN Natural Product Number Available on allocation only the drug is available in limited supply and the manufacturer fills orders based ona pharmacy s past order history see allocation above pharmacies may not be able to order a sufficient supply Back order no date the drug is on back order but there is no estimated delivery date PharmaCare Drug Shortages Lists User Guide Col Co
3. DRUG SHORTAGE LISTS FOR PHARMACARE BENEFITS USER GUIDE READING AND INTERPRETING DRUG SHORTAGE INFORMATION OVERVIEW drame suain mun nein nmnntiseninnib mnn DS 2 dil 2 SIE AUI cH 2 HOW THE INFORMATION IS PRESENTED s sss s ss ss sn sa sa a va eaae o ae oso sssr a 3 FINDING DRUG INFORMATION FAST s sss sso ves ea ano aao aaa Sa ago aa rea eo ae ee na se aeo sa aa ere ae ese seo aeo aa eo go vao sa sa sao ago eas a a gae a seva ovo aso iuo 4 ejfe iy DiolmpilLf 5 DRUG SHORTAGES LISTS COLUMN DETAILS ciccscsissscsscsccsccsscscsscsscsscsscsccsssscasssscsscscsscssoscosssscsscsscsscsscscossosesseess 8 information on theshorted drug ac Ps esio mco oO OO PUDE ORA UDIN 8 Information onthe alternate diis iuvoitoxe ied a n d hare intends ead miei ied fr de ie iae ania eee 9 oru RUE UENIUNT IU HT LU 12 QUESTIONS tt ERE bnnmbi miim immi 12 HN AJEUMDIS PharmaCare Ministry of Health March 2015 PharmaCare Drug Shortages Lists User Guide OVERVIEW PURPOSE The PharmaCare Drug Shortage Lists provide health professionals and the public with up to date information about PharmaCare covered drugs that are in short supply at community pharmacies in B C When a drug that PharmaCare covers is not available or is in such short supply
4. e If an alternate drug is commercially available information will include the drug s trade brand name e If there is no commercially available alternate drug you will see one of the following o No alternative available and no coverage for compounding discuss treatment options with prescriber There is no commercial identical PharmaCare Drug Shortages Lists User Guide Col Column name Description other options product that can substitute for the shorted drug pharmacists will need to talk to the prescribing doctor about other treatment options Compounding allowed only with SA approval PharmaCare may temporarily cover the compound but the doctor must submit a Special Authority request and the pharmacy must submit a Compound Costing Worksheet Both must be approved by PharmaCare s Special Authority SA Program before the pharmacy can make up the compound and submit a claim for the cost Compounding allowed no SA required Pharmacies can compound the prescription and PharmaCare will cover the compound if the pharmacist uses the PIN provided in Column N and charges no more than the maximum reimbursement price in Column P if a price is given Other already covered full benefit versions available Consult the online LCA Data Files for details Other manufacturers make the same drug and they have supplies available for ordering PharmaCare already covers these other versions in the same way as it cov
5. ers the shorted drug They are listed in the LCA Data Files o Other see Notes in column S Strength The per unit strength ofthe mg milligram commercially manufactured e mcg microgram drug that PharmaCare will e ml millilitre In rare instances Special Authority may waive the requirement for a pharmacist submitted compounding costing worksheet Instead it will set a maximum price that PharmaCare will cover for the compound see Column P Max Reimbursement Price for details 10 PharmaCare Drug Shortages Lists User Guide Column name Dosage form Alternate drug DIN PIN Manufacturer Maximum reimbursement price Description temporarily cover during the shortage e g 100 mg 100 mg in each tablet The dosage form of the commercially manufactured drug that PharmaCare will temporarily cover during the shortage e g tablet capsule liquid Drug Identification Number for the alternate commercial product OR Product Identification Number for compounded products that do not need prior Special Authority approval Company that sells the alternate drug Maximum price that PharmaCare will reimburse for the alternate drug during the shortage ee i ee e mg ml milligram per millilitre of liquid Note this list is not complete e This column is often left blank when prior Special Authority approval fora compound is required e This column is left blank when either the
6. es information on the drug that is currently unavailable see description of Columns A through I below 2 Alternate Drug provides information on the replacement drug that PharmaCare will cover temporarily during the shortage see description of Columns J through R below 3 Notes provides additional information on either the shorted drug or the alternate drug s including compounding and other options see description of Column S below Column J shows the date on which information about the shorted drug and or the alternate was last updated ONE DRUG ONE ROW Each shorted drug is listed by its unique Drug Identification Number DIN a separate row is created for each DIN Each DIN may be listed more than once e f PharmaCare covers two or more alternate drugs for a single shorted drug each alternate drug is listed in a separate row e If an alternate drug becomes unavailable or is in short supply it will then also be listed as a shorted drug DATE FORMAT All dates are in YYYY MM DD format to make it easier to sort by date PharmaCare Drug Shortages Lists User Guide FINDING DRUG INFORMATION FAST view the most recent additions and changes view the most recently reported shortages find out which shortages are about to end and thus when PharmaCare temporary coverage of the alternate drug will revert to its usual status find a particular shorted drug Last updated on Column J in descending order t
7. f a generic drug as long as it contains the same active ingredient s same route of administration same dosage form same strength same conditions of use and same bioequivalence that is the same rate and extent of absorption showing no significant difference as the brand name drug only the non medicinal ingredients such as coatings and fillers can differ Generic and brand name drugs have to get approval by Health Canada before they can be sold in Canada Low Cost Alternative LCA category a group of drugs that have the same active ingredients and the same strength A category may contain drugs that have the same or different formulations For example one category for Drug X may contain only 50 mg tablets while another category for Drug X may contain 100 mg tablets and capsules Under the Low Cost Alternative program PharmaCare groups drugs into categories and sets a maximum price that it will allow for each category This maximum price is based on a percentage of the price of the brand name drug If a manufacturer wants its generic drug NS PharmaCare Drug Shortages Lists User Guide included in the list of LCA drugs that PharmaCare covers it has to agree to sell the generic to pharmacies at or below the maximum price PharmaCare covers the drug up to the maximum price plus a fixed markup for pharmacies usually 896 For more information see our LCA program patient information sheet Shorted drug a drug that is e
8. he most recent updates should display at the top of the table Date reported Column A in descending order the most recent additions should display at the top of the table Alternate full coverage end date Column R in ascending order the drugs whose coverage will end soonest should display at the top of the table Select e Chemical name Column B or e Brand or Trade name Column E Then click on the Find amp Select tool in the Excel ribbon and type in the drug s name Sort amp Filter Editing AutoSum gj Fill Q Clear PharmaCare Drug Shortages Lists User Guide GLOSSARY OF TERMS These definitions apply specifically to the PharmaCare drug shortage notification process Active chemical ingredients the ingredient s in the drug that actually do the work such as halting infections or relieving symptoms Most drugs also contain non active ingredients such as fillers Allocation on allocation a method that drug manufacturers use to distribute a drug when it is in short supply Pharmacies receive a proportional share of the limited supply based on their past order history When a drug is available on allocation only PharmaCare temporarily covers an alternate drug if one is available to ensure that patients receive the medication they need Alternate drug a drug that PharmaCare temporarily covers in place of a PharmaCare covered drug that is currently in short supply The a
9. ill be allowed e On this date full benefit coverage of the alternate drug ends The alternate drug s coverage reverts to its usual coverage it may be covered as a partial benefit or a non benefit i e not covered at all e Date is in yyyy mm dd format to allow for sorting by date e Completed only when HIBC confirms that a supply of the shorted drug is once again available for pharmacies to purchase e This column provides additional information on the o status of the shortage o requirements for obtaining Special Authority approvals other issues as appropriate For specific questions about shorted drugs or to report a shortage pharmacists should contact the HIBC Information Support Team at the PharmaNet HelpDesk 212
10. ither unavailable or available in such limited supply that pharmacies may not be able to order enough to meet their patients needs PharmaCare shortage information includes only drugs that are e covered by PharmaCare e reported by community pharmacies in B C the list does not include shorted drugs in hospital or institutional settings When PharmaCare confirms a shortage of a Pharmacare covered drug it publishes information on the PharmaCare coverage options that are available during the shortage Special Authority SA approval for a compounded alternate to a shorted drug approval from the PharmaCare Special Authority Program for coverage of a compounded drug after receipt of a request from a prescriber During a drug shortage PharmaCare may temporarily cover a compounded drug when no other commercially manufactured alternate drug is available In almost all cases coverage of a compounded drug can only be considered if a prescriber submits a request for PharmaCare Special Authority coverage of the compound and the pharmacist submits a Compound Costing Worksheet For the compound to be covered both approvals must be in place before the pharmacist fills the prescription and submits a claim for the compound For a general overview of the Special Authority program see our patient information sheet PharmaCare Drug Shortages Lists User Guide DRUG SHORTAGES LISTS COLUMN DETAILS INFORMATION ON THE SHORTED DRUG Col
11. lternate may be another generic drug or a brand name version of the drug During the shortage PharmaCare temporarily covers the alternate drug in the same way as it covered the drug that is in short supply i e if the drug was covered as a full benefit the alternate will also be covered as a full benefit PharmaCare allows special temporary coverage of an alternate drug only until the drug shortage ends when the drug is available again PharmaCare coverage of the alternate returns to its usual state Brand or Trade name the name the product is sold under Manufacturers may have different trade names for their version of the same drug e g the active chemical ingredient naproxen is sold under several brand names Brand name drug the first formulation version of a new drug that is made up of either a new active chemical or a new combination of active chemicals Brand name drugs are usually patented by their manufacturers so that no one else can manufacture or sell the drug until the patent protection period ends Compare to generic drug Chemical name the scientific name for the active ingredient s of a drug See also Brand Trade name Compound compounded drug a drug product that is made to order compounded for a particular patient by a pharmacist For a compound to be considered for coverage by PharmaCare e no commercially manufactured alternate for the PharmaCare covered shorted drug is available and PharmaCare Drug Shor
12. lumn name Estimated date of availability if known yyyy mm dd Description Estimated date of availability if known INFORMATION ON THE ALTERNATE DRUG Col Column name Last updated on yyyy mm dd Alternate drug Trade Brand name Description Date on which HIBC last updated the shortage information Trade brand name of commercially manufactured drug that PharmaCare will temporarily cover during the shortage OR If there is no commercially manufactured drug available information on e Back order with date the drug is on back order with an estimated delivery date this date is subject to change e Discontinued no longer available the drug is no longer being produced by this manufacturer e Now available pharmacists can now place orders for the shorted drug Coverage of the alternate drug will end on the date in Column R Alternate drug full coverage end date e Date is in yyyy mm dd format to allow for sorting by date e This column is only completed when the manufacturer has provided an estimated shipping date e Important the estimated shipping date is subject to change and should not be thought of as a fixed date e Date is in yyyy mm dd format to allow for sorting by date e When a drug is first listed the date in this column will be the same as the one in Column A e This date is changed whenever HIBC updates information on either the shorted drug or the alternate drug
13. re is no alternate drug available or when PharmaCare will allow temporary coverage of a compounded drug In some instances the shorted drug may be available from other manufacturers whose versions are already covered by PharmaCare These already covered alternates are listed in the online LCA Data Files This column is completed only when HIBC confirms that a commercial supply of the alternate drug is available OR that compounding without prior Special Authority approval of a pharmacist submitted compounding costing worksheet will be allowed Note If PharmaCare already covers the alternate drug the maximum drug price is listed in the online LCA Data Files not here When prior SA approval is required the maximum reimbursement cost is usually included on the approved Compound Costing Worksheet PharmaCare Drug Shortages Lists User Guide Column name Alternate drug full coverage start date Alternate drug full coverage end date Col Column name QUESTIONS For general questions contact Health Insurance BC Description Date on which PharmaCare will start temporarily covering the alternate drug on the same terms as the shorted drug Date on which PharmaCare coverage of the alternate drug returns to its usual state Description e Date is in yyyy mm dd format to allow for sorting by date e Completed only when HIBC confirms that a supply of alternate drug is available OR that compounding w
14. tages Lists User Guide e ahealth care practitioner has to have prescribed the drug for the patient and obtained approval from PharmaCare s Special Authority Program before the drug is dispensed and e the pharmacy making the compound has to get Special Authority approval for the drug compounding cost before the drug is dispensed Compounding the process by which a pharmacist prepares a made to order drug that is based on a practitioner s prescription for a specific patient Discontinued drug a drug that is no longer being made by the manufacturer If the drug is a generic drug other manufacturers may still be making their versions of the product and PharmaCare may cover them as alternates If however there is no other version of the drug there may be no alternative that PharmaCare can cover Drug Identification Number DIN a unique number assigned to a commercially manufactured drug by Health Canada Health Canada assigns a separate number for every strength and dosage form of a drug produced by a manufacturer For example manufacturer X produces a 10 mg and 25 mg tablet and a 50 mg capsule of drug Y Each of these has a separate DIN Formulation the dosage form in which the drug is manufactured e g tablet liquid capsule spray ointment etc Generic drug a drug that contains the same active chemical ingredient or combination of active ingredients as a brand name drug Each manufacturer can create a version o
15. that some pharmacies may not be able to order it the Current Drug Shortages List gives information on the PharmaCare coverage options available during the shortage Pharmacies can check this list to find out what alternate drugs if any that PharmaCare will cover during a shortage so they can order them Prescribers and patients can use this list to find out which drugs will be covered The Resolved Drug Shortages List is a record of PharmaCare covered drug shortages that have ended When a shortage ends PharmaCare switches back to its usual coverage for both the shorted drug and its temporary replacement drug Both lists are updated every business day HOW IT WORKS When a drug shortage is confirmed PharmaCare 1 Checks to see if it already covers another version of the same drug If it does PharmaCare provides information about these other versions in the Current Drug Shortage list 2 If there is no already covered drug available PharmaCare looks for another commercially manufactured version of the drug as a replacement If PharmaCare finds a replacement it temporarily covers this alternate drug until the shortage ends The alternate drug is covered in the same way as the shorted drug for example if the shorted drug required prior approval from PharmaCare s Special Authority SA the alternate drug will also require prior SA approval Information on the replacement drug is given in the Alternate Drug section of the Current

Download Pdf Manuals

image

Related Search

Related Contents

Optica 665  Samsung SEW-HBR144RTJ User Manual  Sandwatch: adaptar-se à mudança climática e - unesdoc  Rabbit Semiconductor 101-0505 Datasheet  USER'S MANUAL      オーロラ保温・保冷散ョッ ピングカート 取扱説明書 取扱説明離は大切に  BEGV606M User Manual  ISOSPIN Plant RNA (PDF 234KB)  

Copyright © All rights reserved.
Failed to retrieve file